Business
BioMarin to Participate in Two Upcoming Virtual Investor Conferences
- 2022 SVB Leerink Global Healthcare Conference on February 18 at 1pm ET - Cowen 42nd Annual Health Care Conference on March 7 at 12:50pm ET SAN RAFAEL,
About this update from Biomarin Pharmaceutical Inc.
[{"type":"text","content":"- 2022 SVB Leerink Global Healthcare Conference on February 18 at 1pm ET\n - Cowen 42nd Annual Health Care Conference on March 7 at 12:50pm ET\n\n\nSAN RAFAEL, Calif., Feb. 16, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual conferences. An audio webcast of the presentations will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.\n\n \n \n \n \n \n \n\n \nAbout BioMarin\nBioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. \nFor additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.\nContacts:\nInvestors\nMedia\nTraci McCarty\nDebra Charlesworth\nBioMarin Pharmaceutical Inc.\nBioMarin Pharmaceutical Inc.\n(415) 455-7558 \n(415) 455-7451\n \n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-two-upcoming-virtual-investor-conferences-301484038.html\nSOURCE BioMarin Pharmaceutical Inc.","length":6449,"tagName":"div"}]